Guanfacine monotherapy for ADHD/ASD comorbid with Tourette syndrome: a case report

被引:0
作者
Kosuke Okazaki
Kazuhiko Yamamuro
Junzo Iida
Toshifumi Kishimoto
机构
[1] Nara Medical University School of Medicine,Department of Psychiatry
[2] Nara Medical University School of Medicine,Faculty of Nursing
来源
Annals of General Psychiatry | / 18卷
关键词
Guanfacine; Atomoxetine; Methylphenidate; Attention deficit/hyperactivity disorder; Autism spectrum disorder; Tourette syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 142 条
[1]  
Scahill L(2000)Epidemiology of ADHD in school-age children Child Adolesc Psychiatr Clin. 9 541-555
[2]  
Schwab-Stone M(2005)Attention-deficit hyperactivity disorder Lancet 366 237-248
[3]  
Biederman J(2001)Should the diagnosis of attention-deficit/hyperactivity disorder be considered in children with pervasive developmental disorder? J Atten Disord. 4 203-211
[4]  
Faraone SV(2004)The clinical necessity for assessing Attention Deficit/Hyperactivity Disorder (AD/HD) symptoms in children with high-functioning pervasive developmental disorder (PDD) Eur Child Adolesc Psychiatry 13 307-314
[5]  
Frazier JA(2015)Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study Atten Defic Hyperact Disord. 7 27-38
[6]  
Biederman J(2004)European clinical guidelines for hyperkinetic disorder—first upgrade Eur Child Adolesc Psychiatry 13 I7-I30
[7]  
Bellordre CA(1998)Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate Am J Psychiatry 155 1325-1331
[8]  
Garfield SB(2002)Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology. 27 699-711
[9]  
Geller DA(1998)Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter J Neurosci 18 2697-2708
[10]  
Coffey BJ(1995)Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55 Brain Res 690 217-224